Related Experiment Video

Updated: Aug 13, 2026

Correlative Light- and Electron Microscopy Using Quantum Dot Nanoparticles
11:16

Correlative Light- and Electron Microscopy Using Quantum Dot Nanoparticles

Published on: August 7, 2016

Endocrine tumours, somatostatin and somatostatin receptors

J Rahier1, Y Guiot, C Sempoux

  • 1Department of Pathology, Cliniques Universitaires Saint Luc, Brussels, Belgium. rahier@anps.ucl.ac.be

Acta Gastro-Enterologica Belgica
|December 14, 2004
PubMed

Insights

Somatostatin inhibits cell division by blocking growth factors. Detecting somatostatin receptors (SSTR1-5) in tumors offers potential therapeutic strategies.

Area of Science:

  • Endocrinology and molecular biology
  • Cancer research and therapeutic targets

Background:

  • Somatostatin is a potent inhibitor of cell division and secretion.
  • It functions by binding to specific somatostatin receptors (SSTRs).
  • Five subtypes of somatostatin receptors (SSTR1-5) exist with distinct tissue expression patterns.

Purpose of the Study:

  • To explore the role of somatostatin and its receptors in biological processes.
  • To investigate the potential of somatostatin receptors as diagnostic and therapeutic targets in oncology.

Main Methods:

  • Review of existing literature on somatostatin and its receptor subtypes.
  • Discussion of histological detection methods for somatostatin receptors in tumor tissues.

Main Results:

  • Somatostatin effectively inhibits growth factor release, impacting cell proliferation and secretion.
  • Somatostatin receptors (SSTR1-5) are expressed in various tissues, including tumors.
  • Histological detection of SSTRs in tumors is feasible.

Conclusions:

  • Somatostatin's inhibitory action on cell division and secretion is mediated via its receptors.
  • The presence and subtypes of somatostatin receptors in tumors hold significant therapeutic potential.
  • Targeting somatostatin receptors could offer novel treatment strategies for various cancers.

More Related Videos

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Concept Videos

Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral stimuli,...